Hepatitis C virus-induced changes in microRNA 107 (miRNA-107) and miRNA-449a modulate CCL2 by targeting the interleukin-6 receptor complex in hepatitis

Journal of Virology

Volumn 88, Issue 7, 2014, Pages 3733-3743

  Sarma, Nayan J ^a   Tiriveedhi, Venkataswarup ^a   Crippin, Jeffrey S ^a   Chapman, William C ^a   Mohanakumar, Thalachallour ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; JANUS KINASE 1; MICRORNA; MICRORNA 107; MICRORNA 499A; MONOCYTE CHEMOTACTIC PROTEIN 1; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LIVER CELL; LIVER FIBROSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SPLEEN FOCUS FORMING VIRUS; UPREGULATION;

ADULT; CHEMOKINE CCL2; FEMALE; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HEPACIVIRUS; HEPATITIS C, CHRONIC; HEPATOCYTES; HOST-PATHOGEN INTERACTIONS; HUMANS; MALE; MICRORNAS; MIDDLE AGED; RECEPTORS, INTERLEUKIN-6; UNITED STATES;

EID: 84895492066     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03060-13     Document Type: Article

References (50)

1. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, Kaslow RA, Margolis HS. 1999. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N. Engl. J. Med. 341:556-562. http://dx.doi.org/10.1056/NEJM199908193410802.
2. Seeff LB. 2002. Natural history of chronic hepatitis C. Hepatology 36:S35-S46. http://dx.doi.org/10.1053/jhep.2002.36806.
3. Carr MW, Roth SJ, Luther E, Rose SS, Springer TA. 1994. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc. Natl. Acad. Sci. U. S. A. 91:3652-3656. http://dx.doi.org/10.1073/pnas.91 .9.3652.
4. Cushing SD, Berliner JA, Valente AJ, Territo MC, Navab M, Parhami F, Gerrity R, Schwartz CJ, Fogelman AM. 1990. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc. Natl. Acad. Sci. U. S. A. 87:5134-5138. http://dx.doi.org/10.1073/pnas.87.13.5134.
5. Standiford TJ, Kunkel SL, Phan SH, Rollins BJ, Strieter RM. 1991. Alveolar macrophage-derived cytokines induce monocyte chemoattractant protein-1 expression from human pulmonary type II-like epithelial cells. J. Biol. Chem. 266:9912-9918.
6. Xu LL, Warren MK, Rose WL, Gong W, Wang JM. 1996. Human recombinant monocyte chemotactic protein and other C-C chemokines bind and induce directional migration of dendritic cells in vitro. J. Leukoc. Biol. 60:365-371.
7. Bertola A, Bonnafous S, Anty R, Patouraux S, Saint-Paul MC, Iannelli A, Gugenheim J, Barr J, Mato JM, Le Marchand-Brustel Y, Tran A, Gual P. 2010. Hepatic expression patterns of inflammatory and immune response genes associated with obesity and NASH in morbidly obese patients. PLoS One 5:e13577. http://dx.doi.org/10.1371/journal.pone.0013577.
8. Degre D, Lemmers A, Gustot T, Ouziel R, Trepo E, Demetter P, Verset L, Quertinmont E, Vercruysse V, Le Moine O, Deviere J, Moreno C. 2012. Hepatic expression of CCL2 in alcoholic liver disease is associated with disease severity and neutrophil infiltrates. Clin. Exp. Immunol. 169: 302-310. http://dx.doi.org/10.1111/j.1365-2249.2012.04609.x.
9. Narumi S, Tominaga Y, Tamaru M, Shimai S, Okumura H, Nishioji K, Itoh Y, Okanoue T. 1997. Expression of IFN-inducible protein-10 in chronic hepatitis. J. Immunol. 158:5536-5544.
10. Zhang C, Li Y, Wu Y, Wang L, Wang X, Du J. 2013. Interleukin-6/signal transducer and activator of transcription 3 (STAT3) pathway is essential for macrophage infiltration and myoblast proliferation during muscle regeneration. J. Biol. Chem. 288:1489-1499. http://dx.doi.org/10.1074/jbc .M112.419788.
11. Hibi M, Murakami M, Saito M, Hirano T, Taga T, Kishimoto T. 1990. Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell 63:1149-1157. http://dx.doi.org/10.1016/0092-8674(90)90411-7.
12. Heinrich PC, Behrmann I, Muller-Newen G, Schaper F, Graeve L. 1998. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem. J. 334:297-314.
13. Huang S. 2007. Regulation of metastases by signal transducer and activator of transcription 3 signaling pathway: clinical implications. Clin. Cancer Res. 13: 1362-1366. http://dx.doi.org/10.1158/1078-0432.CCR-06-2313.
14. Scott EW, Simon MC, Anastasi J, Singh H. 1994. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265: 1573-1577. http://dx.doi.org/10.1126/science.8079170.
15. Kim HG, de Guzman CG, Swindle CS, Cotta CV, Gartland L, Scott EW, Klug CA. 2004. The ETS family transcription factor PU.1 is necessary for the maintenance of fetal liver hematopoietic stem cells. Blood 104:3894-3900. http://dx.doi.org/10.1182/blood-2002-08-2425.
16. Johnson PF. 2005. Molecular stop signs: regulation of cell-cycle arrest by C/EBP transcription factors. J. Cell Sci. 118:2545-2555. http://dx.doi.org /10.1242/jcs.02459.
17. Lu GD, Leung CH, Yan B, Tan CM, Low SY, Aung MO, Salto-Tellez M, Lim SG, Hooi SC. 2010. C/EBPalpha is up-regulated in a subset of hepatocellular carcinomas and plays a role in cell growth and proliferation. Gastroenterology 139:632-643. http://dx.doi.org/10.1053/j.gastro.2010 .03.051.
18. Zeng C, Wang R, Li D, Lin XJ, Wei QK, Yuan Y, Wang Q, Chen W, Zhuang SM. 2010.Anovel GSK-3 beta-C/EBP alpha-miR-122-insulin-like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma. Hepatology 52:1702-1712. http://dx.doi.org/10.1002/hep.23875.
19. Gracias DT, Katsikis PD. 2011. MicroRNAs: key components of immune regulation. Adv. Exp. Med. Biol. 780:15-26. http://dx.doi.org/10.1007 /978-1-4419-5632-3_2.
20. McManus MT. 2003. MicroRNAs and cancer. Semin. Cancer Biol. 13: 253-258. http://dx.doi.org/10.1016/S1044-579X(03)00038-5.
21. Sarma NJ, Tiriveedhi V, Ramachandran S, Crippin J, Chapman W, Mohanakumar T. 2012. Modulation of immune responses following solid organ transplantation by microRNA. Exp. Mol. Pathol. 93:378-385. http: //dx.doi.org/10.1016/j.yexmp.2012.09.020.
22. Girard M, Jacquemin E, Munnich A, Lyonnet S, Henrion-Caude A. 2008. miR-122, a paradigm for the role of microRNAs in the liver. J. Hepatol. 48:648-656. http://dx.doi.org/10.1016/j.jhep.2008.01.019.
23. Sarma NJ, Tiriveedhi V, Subramanian V, Shenoy S, Crippin JS, Chapman WC, Mohanakumar T. 2012. Hepatitis C virus mediated changes in miRNA-449a modulates inflammatory biomarker YKL40 through components of the NOTCH signaling pathway. PLoS One 7:e50826. http://dx .doi.org/10.1371/journal.pone.0050826.
24. Sarma NJ, Yaseen NR. 2011. Amino-terminal enhancer of split (AES) interacts with the oncoprotein NUP98-HOXA9 and enhances its transforming ability. J. Biol. Chem. 286:38989-39001. http://dx.doi.org/10 .1074/jbc.M111.297952.
25. Ramachandran S, Ilias Basha H, Sarma NJ, Lin Y, Crippin JS, Chapman WC, Mohanakumar T. 2013. Hepatitis C virus induced miR200c down modulates FAP-1, a negative regulator of Src signaling and promotes hepatic fibrosis. PLoS One 8:e70744. http://dx.doi.org/10.1371/journal.pone.0070744.
26. Nishitsuji H, Funami K, Shimizu Y, Ujino S, Sugiyama K, Seya T, Takaku H, Shimotohno K. 2013. HCV infection induces inflammatory cytokines and chemokines mediated by the cross-talk between hepatocytes and stellate cells. J. Virol. http://dx.doi.org/10.1128/JVI.00974-13.
27. Basha HI, Subramanian V, Seetharam A, Nath DS, Ramachandran S, Anderson CD, Shenoy S, Chapman WC, Crippin JS, Mohanakumar T. 2011. Characterization of HCV-specific CD4Th17 immunity in recurrent hepatitis C-induced liver allograft fibrosis. Am. J. Transplant. 11:775-785. http://dx.doi.org/10.1111/j.1600-6143.2011.03458.x.
28. Marra F, Romanelli RG, Giannini C, Failli P, Pastacaldi S, Arrighi MC, Pinzani M, Laffi G, Montalto P, Gentilini P. 1999. Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells. Hepatology 29:140-148. http://dx.doi.org/10.1002/hep.510290107.
29. Muhlbauer M, Bosserhoff AK, Hartmann A, Thasler WE, Weiss TS, Herfarth H, Lock G, Scholmerich J, Hellerbrand C. 2003. A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease. Gastroenterology 125:1085-1093. http://dx.doi.org/10.1016/S0016-5085(03)01213-7.
30. Seki E, de Minicis S, Inokuchi S, Taura K, Miyai K, van Rooijen N, Schwabe RF, Brenner DA. 2009. CCR2 promotes hepatic fibrosis in mice. Hepatology 50:185-197. http://dx.doi.org/10.1002/hep.22952.
31. Baeck C, Wehr A, Karlmark KR, Heymann F, Vucur M, Gassler N, Huss S, Klussmann S, Eulberg D, Luedde T, Trautwein C, Tacke F. 2012. Pharmacological inhibition of the chemokineCCL2(MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury. Gut 61:416-426. http: //dx.doi.org/10.1136/gutjnl-2011-300304.
32. Galastri S, Zamara E, Milani S, Novo E, Provenzano A, Delogu W, Vizzutti F, Sutti S, Locatelli I, Navari N, Vivoli E, Caligiuri A, Pinzani M, Albano E, Parola M, Marra F. 2012. Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitis. Clin. Sci. 123:459-471. http://dx.doi.org/10.1042/CS20110515.
33. Machida K, Cheng KT, Sung VM, Levine AM, Foung S, Lai MM. 2006. Hepatitis C virus induces Toll-like receptor 4 expression, leading to enhanced production of beta interferon and interleukin-6. J. Virol. 80:866-874. http://dx.doi.org/10.1128/JVI.80.2.866-874.2006.
34. Biswas P, Delfanti F, Bernasconi S, Mengozzi M, Cota M, Polentarutti N, Mantovani A, Lazzarin A, Sozzani S, Poli G. 1998. Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line. Blood 91:258-265.
35. Huang J, Zhang JS, Huang GC, Tang QQ, Chen C, Zhang XR, Chen Q. 2004. Expression of CCAAT/enhancer-binding protein in cultured rat hepatic stellate cells and its significance. Zhonghua Gan Zang Bing Za Zhi 12:259-262.
36. Tao LL, Cheng YY, Ding D, Mei S, Xu JW, Yu J, Ou-Yang Q, Deng L, Chen Q, Li QQ, Xu ZD, Liu XP. 2012. C/EBP-alpha ameliorates CCl(4)-induced liver fibrosis in mice through promoting apoptosis of hepatic stellate cells with little apoptotic effect on hepatocytes in vitro and in vivo. Apoptosis 17:492-502. http://dx.doi.org/10.1007/s10495-012-0700-y.
37. Martin P, D'Souza D, Martin J, Grose R, Cooper L, Maki R, McKercher SR. 2003. Wound healing in the PU.1 null mouse: tissue repair is not dependent on inflammatory cells. Curr. Biol. 13:1122-1128. http://dx.doi .org/10.1016/S0960-9822(03)00396-8.
38. Oelgeschlager M, Nuchprayoon I, Luscher B, Friedman AD. 1996. C/EBP, c-Myb, and PU.1 cooperate to regulate the neutrophil elastase promoter. Mol. Cell. Biol. 16:4717-4725.
39. Smith LT, Hohaus S, Gonzalez DA, Dziennis SE, Tenen DG. 1996. PU.1 (Spi-1) and C/EBP alpha regulate the granulocyte colony-stimulating factor receptor promoter in myeloid cells. Blood 88:1234-1247.
40. Hegde S, Ni S, He S, Yoon D, Feng GS, Watowich SS, Paulson RF, Hankey PA. 2009. Stat3 promotes the development of erythroleukemia by inducing Pu.1 expression and inhibiting erythroid differentiation. Oncogene 28:3349-3359. http://dx.doi.org/10.1038/onc.2009.202.
41. Potula HS, Wang D, Quyen DV, Singh NK, Kundumani-Sridharan V, Karpurapu M, Park EA, Glasgow WC, Rao GN. 2009. Src-dependent STAT-3-mediated expression of monocyte chemoattractant protein-1 is required for 15(S)-hydroxyeicosatetraenoic acid-induced vascular smooth muscle cell migration. J. Biol. Chem. 284:31142-31155. http://dx .doi.org/10.1074/jbc.M109.012526.
42. McCartney EM, Helbig KJ, Narayana SK, Eyre NS, Aloia AL, Beard MR. 22 May 2013. Signal transducer and activator of transcription 3 (STAT3) is a pro-viral host factor for hepatitis C virus. Hepatology http://dx.doi.org /10.1002/hep.26496.
43. He Y, Huang C, Zhang SP, Sun X, Long XR, Li J. 2012. The potential of microRNAs in liver fibrosis. Cell Signal. 24:2268-2272. http://dx.doi.org /10.1016/j.cellsig.2012.07.023.
44. He Y, Huang C, Sun X, Long XR, Lv XW, Li J. 2012. MicroRNA-146a modulates TGF-beta1-induced hepatic stellate cell proliferation by targeting SMAD4. Cell Signal. 24:1923-1930. http://dx.doi.org/10.1016/j.cellsig .2012.06.003.
45. McCoy CE. 2012. The role of miRNAs in cytokine signaling. Front. Biosci. 17:2161-2171.
46. Furuta M, Kozaki KI, Tanaka S, Arii S, Imoto I, Inazawa J. 2010. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 31:766-776. http://dx.doi.org/10.1093/carcin/bgp250.
47. Hatziapostolou M, Polytarchou C, Aggelidou E, Drakaki A, Poultsides GA, Jaeger SA, Ogata H, Karin M, Struhl K, Hadzopoulou-Cladaras M, Iliopoulos D. 2011. An HNF4alpha-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis. Cell 147:1233-1247. http://dx .doi.org/10.1016/j.cell.2011.10.043.
48. Jia HY, Wang YX, Yan WT, Li HY, Tian YZ, Wang SM, Zhao HL. 2012. MicroRNA-125b functions as a tumor suppressor in hepatocellular carcinoma cells. Int. J. Mol. Sci. 13:8762-8774. http://dx.doi.org/10.3390 /ijms13078762.
49. Gong G, Waris G, Tanveer R, Siddiqui A. 2001. Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B. Proc. Natl. Acad. Sci. U. S. A. 98:9599-9604. http://dx.doi.org/10.1073/pnas.171311298.
50. Yoshida T, Hanada T, Tokuhisa T, Kosai K, Sata M, Kohara M, Yoshimura A. 2002. Activation of STAT3 by the hepatitis C virus core protein leads to cellular transformation. J. Exp. Med. 196:641-653. http: //dx.doi.org/10.1084/jem.20012127.